NATIXIS

Position in EXEL — Exelixis, Inc.

CIK 1274981 PARIS, I0

Position in EXEL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,585,840

+$6,480,288 QoQ

Shares Held

121,041

+4818.4% QoQ

Ownership

0.049%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#150

of 739 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NATIXIS holds $65,699,213 across 42 Biotechnology names. EXEL ranks #3 (10.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	59,095	$29,354,259
2	CORT	Corcept Therapeutics Inc	109,905	$9,556,239
3	EXEL	Exelixis, Inc. This page	121,041	$6,585,840
4	MRNA	Moderna, Inc.	66,370	$4,647,891
5	REGN	Regeneron Pharmaceuticals, Inc.	6,599	$4,114,740
6	CAI	Caris Life Sciences, Inc.	124,716	$2,222,439
7	RVMD	Revolution Medicines, Inc.	8,467	$1,585,699
8	PTGX	Protagonist Therapeutics, Inc	7,776	$953,182

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,585,840	121,041	+4818.4%	Shares	Sole	2026-08-13
2026-03-31	$105,552	2,461	-87.4%	Shares	Sole	2026-05-14
2025-12-31	$853,107	19,464	-61.6%	Shares	Sole	2026-02-13
2025-09-30	$2,094,942	50,725	+33.2%	Shares	Sole	2025-11-14
2024-09-30	$987,864	38,068	+3806700.0%	Shares	Sole	2024-11-13
2024-06-30	$22	1	0.0%	Shares	Sole	2024-08-13
2024-03-31	$23	1	-99.8%	Shares	Sole	2024-05-13
2023-12-31	$11,899	496	-86.6%	Shares	Sole	2024-02-13
2022-12-31	$59,428	3,705	-89.6%	Shares	Sole	2023-02-24
2021-06-30	$646,810	35,500	+148.3%	Shares	Sole	2021-08-13
2020-12-31	$287,001	14,300	-64.1%	Shares	Sole	2021-02-12
2020-06-30	$946,917	39,887	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.